Pegvisomant-induced lipohypertrophy: report of a case with histopathology.
Marazuela
Monica
M
Daudén
Esteban
E
Ocón
Elena
E
Moure
Dolores
D
Nattero
Lia
L
D000005:Abdomen; D000172:Acromegaly / Q000188:drug therapy; D005260:Female; D019382:Human Growth Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D007279:Injections, Subcutaneous / Q000009:adverse effects; D007334:Insulin-Like Growth Factor I / Q000378:metabolism*; D008060:Lipodystrophy / Q000139:chemically induced* / Q000378:metabolism / Q000473:pathology*; D008875:Middle Aged
D019382:Human Growth Hormone; D007334:Insulin-Like Growth Factor I; C406545:pegvisomant